Geographical Distribution and Underlying Diseases of Patients with COVID-19 Referred to Afzalipour Hospital in Kerman city

Document Type : Short Communication


1 Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

2 Department of Health Information Sciences, Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran


Background: COVID-19 is a novel disease that infected many people around the world. It is essential to find the potential high-risk locations and provide suitable healthcare interventions to control COVID-19 distribution. Using a geographic information system, this study aimed to investigate the distribution trends of patients with COVID-19 in Kerman, Iran.
Methods: The information of registered patients of Afzalipour hospital in Kerman city who were admitted before July 22, 2020, was collected and used in this paper. The patients’ addresses were converted into geocodes. The trend of disease prevalence in connection with population density in different parts of Kerman was investigated. After that, the average nearest neighbor analysis was performed to check the random distribution of disease cases. Data were checked for randomness by High/Low clustering analysis.
Results: : The spread of the COVID-19 disease started in Kerman city’s north, south, and west and then distributed to the center. The southern and western regions were in high-high clusters, and the central and northern regions were in low-low clusters in terms of COVID-19 outbreak risk. Regression showed a significant correlation between underlying diseases and patients' age with the incidence of Covid-19 disease.
Conclusion: The prevalence of COVID-19 had been higher in densely populated areas and also in areas with poorer economic conditions. Therefore, paying attention to these areas as well as applying strict rules can help control the spread of COVID-19. The result of this study could be useful for public health experts and healthcare managers to manage better this pandemic.


  1. World Health Organization. Coronaviruses (COVID-19); 2020. [cited 17 April 2020]. Available from:
  2. COVID-19 Coronavirus Pandemic; 2020. [cited 17 October 2020]. Available from:
  3. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19); 2020. [cited 9 September 2020]. Available from:
  4. Kirby RS, Delmelle E, Eberth JM. Advances in spatial epidemiology and geographic information systems. Ann Epidemiol. 2017; 27(1):1-9. doi: 10.1016/j.annepidem.2016.12.001. 
  5. Diez Roux AV. Investigating neighborhood and area effects on health. Am J Public Health. 2001; 91(11):1783-9. doi: 10.2105/ajph.91.11.1783.
  6. Cromley EK, McLafferty SL. GIS and public health. New York: Guilford Press; 2011.
  7. Carroll LN, Au AP, Detwiler LT, Fu TC, Painter IS, Abernethy NF. Visualization and analytics tools for infectious disease epidemiology: A systematic review. J Biomed Inform. 2014; 51:287-98. doi: 10.1016/j.jbi.2014.04.006.
  8. Thahir-Silva S, Betancourt-Trejos ML, Garcia-Loaiza CJ, Villegas-Rojas S, Cardona-Ospina JA, Lagos-Grisales GJ, et al. Mapping zika in the 125 municipalities of Antioquia department of Colombia using Geographic Information System (GIS) during 2015-2016 outbreak. Infez Med. 2018; 26(2):178-80. 
  9. Quinn E, Hsiao K, Truman G, Rose N, Broome R. Lessons learnt from exercise celestial navigation: The application of a geographic information system to inform legionnaires' disease control activity. Disaster Med Public Health Prep. 2019; 13(2):372-4. doi: 10.1017/dmp.2018.40.
  10. Chen Q, Lai S, Yin W, Zhou H, Li Y, Mu D, et al. Epidemic characteristics, high-risk townships and space-time clusters of human brucellosis in Shanxi Province of China, 2005-2014. BMC Infect Dis. 2016; 16(1):760. doi: 10.1186/s12879-016-2086-x.
  11. Andrade LA, Gomes DS, Góes MAdO, Souza MSFd, Teixeira DCP, Ribeiro CJN, et al. Surveillance of the first cases of COVID-19 in Sergipe using a prospective spatiotemporal analysis: The spatial dispersion and its public health implications. Revista da Sociedade Brasileira de Medicina Tropical. 2020; 53:e20200287. doi: 10.1590/0037-8682-0287-2020.
  12. Huang C, Xu X, Cai Y, Ge Q, Zeng G, Li X, et al. Mining the characteristics of COVID-19 patients in China: Analysis of Social Media Posts. J Med Internet Res. 2020; 22(5):e19087. doi: 10.2196/19087.
  13. September 20 and the latest corona news in the provinces; 2020. [cited 20 September 2020]. Available from: [In Persian]
  14. Kerman; 2021. [cited 13 March 2021]. Available from: [In Persian]
  15. Haghdoost AA, Baneshi MR, Haji-Maghsoodi S, Molavi-Vardanjani H, Mohebbi E. Application of a network scale-up method to estimate the size of population of breast, ovarian/cervical, prostate and bladder cancers. Asian Pac J Cancer Prev. 2015; 16(8):3273-7. doi: 10.7314/apjcp.2015.16.8.3273.
  16. Sharifi A, Khavarian-Garmsir AR. The COVID-19 pandemic: Impacts on cities and major lessons for urban planning, design, and management. Sci Total Environ. 2020; 749:142391. doi: 10.1016/j.scitotenv.2020.142391.
  17. von Seidlein L, Alabaster G, Deen J, Knudsen J. Crowding has consequences: Prevention and management of COVID-19 in informal urban settlements. Build Environ. 2021; 188:107472. doi: 10.1016/j.buildenv.2020.107472.
  18. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.  J Clin Virol. 2020; 127:104378. doi: 10.1016/j.jcv.2020.104378.
  19. Shoss MK, Horan KA, DiStaso M, LeNoble CA, Naranjo A. The conflicting impact of COVID-19’s health and economic crises on helping. Group & Organization Management. 2021; 46(1):3-37. doi: 10.1177/1059601120968704.
  20. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory Syndrome Coronavirus (MERS-CoV): A systematic review and meta-analysis. Int J Infect Dis. 2016; 49:129-33. doi: 10.1016/j.ijid.2016.06.015.
  21. Zhao H, Lu X, Deng Y, Tang Y, Lu J. COVID-19: asymptomatic carrier transmission is an underestimated problem. Epidemiol Infect. 2020; 148:e116. doi: 10.1017/S0950268820001235.